Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131
Open Access
- 1 April 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 11 (2), 167-175
- https://doi.org/10.1215/15228517-2008-073
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Survey of treatment recommendations for anaplastic oligodendrogliomaNeuro-Oncology, 2007
- A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with OligodendrogliomaCancer Research, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971Journal of Clinical Oncology, 2003
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtypeOncogene, 1999
- Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trialsCancer Treatment Reviews, 1997
- Procarbazine, lomustine, and vincristine (PCV) chemotherapy for Grade III and Grade IV oligoastrocytomasJournal of Neurosurgery, 1996
- Oligodendroglioma: incidence and biological behavior in a defined populationJournal of Neurosurgery, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958